Alzheimer’s disease patients typically have lower plasma HDL cholesterol (HDL-C) and apolipoprotein-A1 (ApoA-I) concentrations than controls [3,4], suggesting that a lack of HDL is detrimental. This evidence concerns the gene APOA1 and Alzheimer disease.